Connect with us


PE fund swoops for medtech manufacturer EUROPIN

The private equity fund of Gilde Healthcare, a specialist healthcare investor, has acquired global medtech firm EUROPIN.

Avatar photo



The private equity fund of Gilde Healthcare, a specialist healthcare investor, has acquired EUROPIN, a global developer and manufacturer of customised pen cannulas and lancet needles for diabetic use.

The acquisition of EUROPIN enables Gilde Healthcare to form an integrated contract manufacturer for cannulas and cannula systems, following its initial investment in German medtech company Acti-Med, less than 12 months ago.

By joining forces, EUROPIN and Acti-Med “will be able to significantly expand” its footprint – in terms of geography as well as breadth and depth of the product portfolio, the company said.

It will represent one of the largest contract manufacturers of raw cannulas and cannula systems in Europe.

Headquartered in Heidelberg, Germany, with a development and production plant in Trenčín, Slovakia, EUROPIN develops and manufactures medical needles, such as pen cannulas and lancet needles for medical and pharmaceutical applications with a focus on injection systems for self-medication in the field of diabetes and hormone therapies.

It was founded in 1997 and has strengthened its market positioning in recent years by evolving its product portfolio to become one of the European leaders in its market, with an annual output of more than two billion needles and cannulas.

Acti-Med was acquired by Gilde Healthcare last April. The company focuses on cannulas and cannula systems for pharmaceutical and medical applications, jointly developed with international Original Equipment Manufacturers (OEMs).
It is headquartered in Freiensteinau, Germany, and with operations in Kozerkí, Poland, and a global customer base.

Lothar Lindenau, CEO of EUROPIN, said: “We are very proud of the development of EUROPIN which we have achieved with our team over the last years.

“We are pleased to have a new partner at our side and look forward to the next steps we will jointly pursue. We are convinced that joining forces with Acti-Med will bring great value to both companies and help build a global leader.”


Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending stories